Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recommend triple therapy, especially in the course of acute coronary syndrome (ACS), with limitations due to an excessive risk of bleeding associated with this therapeutic regimen. This review summarizes randomized clinical trials and observational studies that compared triple therapy with a variety of different therapeutic options. Although the available evidence is not completely satisfactory and other studies are urgently needed, alternative regimens to triple therapy in AF patients undergoing PCI and stenting are promising, at least in terms of safety.

DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation / Di Bari M.; Pratesi A.; Nigro F.M.; Marozzi I.; Fumagalli S.. - In: MONALDI ARCHIVES FOR CHEST DISEASE. - ISSN 1122-0643. - ELETTRONICO. - 88:(2018), pp. 32-34. [10.4081/monaldi.2018.957]

DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation

Di Bari M.;Pratesi A.;Nigro F. M.;Marozzi I.;Fumagalli S.
2018

Abstract

Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recommend triple therapy, especially in the course of acute coronary syndrome (ACS), with limitations due to an excessive risk of bleeding associated with this therapeutic regimen. This review summarizes randomized clinical trials and observational studies that compared triple therapy with a variety of different therapeutic options. Although the available evidence is not completely satisfactory and other studies are urgently needed, alternative regimens to triple therapy in AF patients undergoing PCI and stenting are promising, at least in terms of safety.
2018
88
32
34
Goal 3: Good health and well-being for people
Di Bari M.; Pratesi A.; Nigro F.M.; Marozzi I.; Fumagalli S.
File in questo prodotto:
File Dimensione Formato  
DiBari_Monaldi_2018.pdf

accesso aperto

Descrizione: Articolo
Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 537.51 kB
Formato Adobe PDF
537.51 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1174113
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact